Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis

Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis

Abstract Background The optimal treatment algorithm for iron therapy and the use of erythropoiesis-stimulating agents (ESA) in anemic hemodialysis (HD) patients has not been established. Hemoglobin (Hb) target levels can be achieved through more frequent intravenous (IV) iron use with lower ESA dose...

Full description

Bibliographic Details
Main Authors: Maciej Drozdz, André Weigert, Fatima Silva, João Frazão, Abdulkareem Alsuwaida, Mahesh Krishnan, Werner Kleophas, Szymon Brzosko, Fredrik K. Johansson, Stefan H. Jacobson
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Nephrology
Subjects:
Anemia
Erythropoiesis-stimulating agent
Ferritin
Hemodialysis
Hemoglobin
Iron
Online Access:http://link.springer.com/article/10.1186/s12882-018-1196-7

Internet

http://link.springer.com/article/10.1186/s12882-018-1196-7

Similar Items